Up to 45 percent of patients with critical limb ischemia (CLI) are rehospitalized within 90 days. Dr. Mehdi Shishehbor shares insights on how to curb that rate from important publications on CLI over the past year.
New PAD Guidelines Stress Comprehensive Care, Endorse Structured Exercise
The new AHA/ACC recommendations on peripheral artery disease (PAD) extend more broadly across the spectrum of PAD care. The guidelines’ vice chair explains why they’re more of a reboot than an update.
New Option Offers Hope for Inoperable CTEPH
Up to 40 percent of patients with chronic thromboembolic pulmonary hypertension aren’t eligible for surgery. For them, balloon pulmonary angioplasty is emerging as a highly promising new therapy.
Critical Limb Ischemia: National Snapshot of Its Management Holds a Few Surprises
Rates of surgery for CLI are going down as rates of endovascular procedures surge. Meanwhile hospital admissions for CLI are holding constant. So reports a huge new nationwide analysis of CLI care.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
To Diagnose Critical Limb Ischemia, Look to the Toe as Well as the Ankle
A substudy of the IN.PACT DEEP trial shows that the ankle-brachial index identifies CLI in only 6 percent of affected patients. The researchers say guideline revisions and better diagnostic tools are needed.
Here’s Your Chance to Gain Mastery in Managing Critical Limb Ischemia
In April, Cleveland Clinic hosts a faculty of world experts for a CME event called Masters’ Approach to Critical Limb Ischemia. All aspects of CLI and limb salvage will be covered in a mix of hands-on workshops, live case demonstrations, succinct expert talks and panel discussions.
Post-Exercise ABI Beats Resting ABI as Predictor of Revascularization in PAD
A large retrospective analysis finds the ankle-brachial index to better predict lower extremity revascularization rates when measured after exercise than at rest. here’s how the lead author says practice should change.
Endovascular Treatment of Fem-Pop Lesions: Where Do We Stand After IN.PACT SFA?
One expert’s take on the IN.PACT SFA trial: Despite outstanding 24-month results with a drug-coated balloon for moderately long lesions, there’s still no clear standard of care for femoropopliteal lesions.
Conquering Chronic Total Occlusion Lesions
When an ischemic peripheral lesion cannot be crossed using the typical antegrade approach, tibiopedal retrograde access often raises the chance of success and allows angioplasty to proceed.